Acadia Pharmaceuticals (ACAD) EPS (Basic) (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly EPS (Basic) of $0.02 for Q1 2026, down 81.26% year-over-year from $0.11 in Q1 2025, and down 98.69% quarter-over-quarter from $1.62 in Q4 2025.
Acadia Pharmaceuticals (ACAD) EPS (Basic) (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.02 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 81.26% year-over-year to $0.02; the TTM figure through Mar 2026 stood at $2.2 (up 60.55% YoY), while the FY2025 annual figure was $2.32, up 69.96% from the prior year.
- EPS (Basic) for Q1 2026 stood at $0.02, down from $1.62 in the prior quarter.
- The five-year high for EPS (Basic) was $279.56 in Q4 2023, with the low at -$396.85 in Q3 2023.
- The 5-year median for EPS (Basic) is $0.11 (2025), against an average of -$43.74.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 186442.28% in 2022, then soared 208.54% in 2023.
- Acadia Pharmaceuticals' EPS (Basic) stood at -$257.57 in 2022, then jumped by 208.54% to $279.56 in 2023, then slumped by 99.69% to $0.87 in 2024, then soared by 87.34% to $1.62 in 2025, then plunged by 98.69% to $0.02 in 2026.
- Business Quant data shows ACAD's EPS (Basic) at $0.02 in Q1 2026, $1.62 in Q4 2025, and $0.43 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | 0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.18 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 1.62 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.20 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 279.56 |
| Sep 30, 2023 | -396.85 |
| Jun 30, 2023 | 6.82 |
| Mar 31, 2023 | -0.27 |
| Dec 31, 2022 | -257.57 |
| Sep 30, 2022 | -167.86 |
| Jun 30, 2022 | -210.39 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | -0.29 |
| Sep 30, 2021 | -0.09 |